In DKD mice, continuous administration of FTZPs could also dramatically lower the expression of the pro-inflammatory cytokines chemokine (C–C motif) ligand 2, IL-6, and intercellular adhesion molecule-1 (ICAM-1). The gene discussed is ICAM1; the disease is diabetic kidney disease.